CYRX News and Press, CryoPort Inc. From 09/08/22

Cold-storage logistics company Cryoport ( NASDAQ: CYRX ) on Thursday said it had entered into a strategic relationship with BioLife Plasma Services, part of Japanese pharmaceutical major Takeda ( TAK ), to establish a supply chain platform. CYRX and BioLife will aim to...

Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services PR Newswire Cryoport plans to establish an integrated supply chain platform with BioLife Plasma Services to offer standardized cell therapy collection, processing, and storage services in...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the second quarter, the Baron Discovery Fund was down 22.66% (Institutional Shares), which was 3.41% below the Russell...

Cryoport, Inc. (CYRX) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Todd Fromer – Managing Partner-KCSA Jerrell Shelton – Chief Executive Officer Tom Heinzen – Vice President, Corporate Development and Invest...

CryoPort press release ( NASDAQ: CYRX ): Q2 GAAP EPS of -$0.23. Revenue of $64.2M (+14.3% Y/Y). The Company expects that its revenue guidance for the full year 2022 of $260 - $265 million For further details see: CryoPort GAAP EPS of -$0.23, revenue of $64.2M...

Cryoport Reports Results for the Second Quarter 2022 PR Newswire Record revenue of $64.2 million for the quarter, up 14% as reported and 18% at constant currency (year-over-year) Supporting a record 626 global clinical trials; a net of 17 new trials added...

Cryoport has done well to grow its top line in recent years and some bottom line figures have also fared well. Growth is expected to continue this year, but this doesn't make the company a wise investment. Shares look very expensive right now and are unlikely to offer material ups...

Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022 PR Newswire NASHVILLE, Tenn. , July 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chai...

We conclude our roundtable series with Biotech and Healthcare coverage. Seven of our Marketplace contributors give their analysis and share one top idea. Look for more roundtables and analysis this summer from our community of 180+ Marketpalce services. ~ By Tim Murphy, Ma...

Biopharmaceutical stocks have undergone a dramatic correction over the past six months, with the XBI declining by 45%. The decline was appropriate, given the number of companies that went public in 2021 with preclinical data and a valuation exceeding $1 billion. Not only would the...